SuperworthChina Pharma shares outstanding CPHI
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 40.5M
- On a year earlier
- +1156.0%
- more shares
China Pharma had 40.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1156.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 6.7M | +192% |
| FY2024 | 2.3M | +218% |
| FY2023 | 723.8K | +658% |
| FY2021 | 95.5K | +9% |
| FY2020 | 87.5K | +0% |
| FY2019 | 87.2K | +0% |
| FY2018 | 87.2K | +0% |
| FY2017 | 87.2K | +0% |
| FY2016 | 87.2K | +0% |
| FY2015 | 87.2K | −0% |
| FY2012 | 87.3K | +0% |
| FY2011 | 87.1K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 40.5M | +1156% | |
| Q1 FY26 | 25.6M | +685% | |
| Q4 FY25 | 6.7M | +192% | |
| Q3 FY25 | 3.9M | +124% | |
| Q2 FY25 | 3.2M | +100% | |
| Q1 FY25 | 3.3M | +145% | |
| Q4 FY24 | 2.3M | +218% | |
| Q3 FY24 | 1.7M | +555% | |
| Q2 FY24 | 1.6M | n/a | |
| Q1 FY24 | 1.3M | n/a | |
| Q4 FY23 | 723.8K | n/a | |
| Q3 FY23 | 264.3K | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on China Pharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.